COVID-19 Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection

DB15845Experimental

As of July 2020, Medicine Invention Design, Inc. is sponsoring a small, controlled clinical trial for the COVID-19 AP TP Vaccine for ‘proof of concept.’ The vaccine utilizes granulocyte macrophage-colony...

Also known as
AP-TP-V · COVID-19 AP TP Vaccine · COVID-19 Therapeutic Vaccine - Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection
Code names
COVID-19 Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection

What you can answer from here — as of March 06, 2025

2+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of COVID-19 Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account